1.
Artificial intelligence-enabled rapid diagnosis of patients with COVID-19
by Mei, Xueyan
Nature medicine, 2020-08, Vol.26 (8), p.1224-1228
2.
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study
by Tawakol, Ahmed, Dr
The Lancet (British edition), 2017, Vol.389 (10071), p.834-845
3.
The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis
by Calcagno, Claudia
European journal of nuclear medicine and molecular imaging, 2013-08-14, Vol.40 (12), p.1884-1893
4.
Simultaneous carotid PET/MR: feasibility and improvement of magnetic resonance-based attenuation correction
by Bini, Jason
The International Journal of Cardiovascular Imaging, 2015-04-22, Vol.32 (1), p.61-71
5.
6.
Relationship between particulate matter exposure and atherogenic profile in “Ground Zero” workers as shown by dynamic contrast enhanced MR imaging
by Mani, Venkatesh
International Journal of Cardiovascular Imaging, 2012-11-23, Vol.29 (4), p.827-833
7.
The complementary roles of dynamic contrast-enhanced MRI and F-18-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis
by Calcagno, Claudia
European journal of nuclear medicine and molecular imaging, 2013-12, Vol.40 (12), p.1884-1893
8.
The complementary roles of dynamic contrast-enhanced MRI and 18.sup.F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis
by Calcagno, Claudia
European journal of nuclear medicine and molecular imaging, 2013-12-01, Vol.40 (12), p.1884
9.
The complementary roles of dynamic contrast-enhanced MRI and super(18)F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis
by Calcagno, Claudia
European journal of nuclear medicine and molecular imaging, 2013-12-01, Vol.40 (12), p.1884-1893
10.
The complementary roles of dynamic contrast-enhanced MRI and ^sup 18^F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis
by Claudia Calcagno
European journal of nuclear medicine and molecular imaging, 2013-12-01, Vol.40 (12), p.1884
11.
12.
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
by Garassino, Marina Chiara, MD
The lancet oncology, 2013, Vol.14 (10), p.981-988
13.
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses...
by Rossi, Alessandro
European archives of psychiatry and clinical neuroscience, 2016-07-06, Vol.267 (4), p.285-294
